The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Hemicrania Continua — Advanced Concepts

Strictly unilateral, continuous, side-locked headache with cranial autonomic features and absolute response to indomethacin, classified as a trigeminal autonomic cephalalgia and managed with indomethacin trial, alternative therapies for indomethacin-intolerant patients, and emerging neuromodulation.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Nöroloji department. Book Appointment →

What is Hemicrania Continua — Advanced Concepts?

Hemicrania continua (HC) is a primary headache disorder of the trigeminal autonomic cephalalgias group, characterized by strictly unilateral, side-locked, continuous (background pain present every day) head pain of moderate intensity with periodic exacerbations, accompanied by ipsilateral cranial autonomic features and a complete response to indomethacin (the indotest).

Pathophysiology involves dysregulation of the trigemino-vascular system and central nociceptive pathways, with hypothalamic activation demonstrated on functional imaging during exacerbations; ipsilateral cranial autonomic symptoms reflect activation of the trigeminoautonomic reflex.

Diagnosis requires unilateral pain for more than 3 months, exacerbations associated with cranial autonomic symptoms or restlessness, complete indomethacin responsiveness (typically 75–225 mg daily), and exclusion of secondary mimics by imaging when atypical features are present.

Symptoms

Continuous, strictly unilateral, side-locked headache lasting more than 3 months
Moderate baseline pain with episodic severe exacerbations lasting minutes to days
Ipsilateral cranial autonomic features during exacerbations: conjunctival injection, lacrimation, ptosis, miosis, nasal congestion or rhinorrhea, eyelid edema
Restlessness or agitation during severe exacerbations (similar to cluster headache)
No side shift, no remission periods, no shifts to bilateral pain
Complete and sustained relief with adequate dose of indomethacin

Risk Factors

Female sex, with adult onset typical (mean age in fourth decade)
Family or personal history of migraine, increasing diagnostic confusion
Comorbid mental health conditions (depression, anxiety) related to chronic pain
Coexistent neck or temporomandibular disorders contributing to differential diagnosis
Risk factors for indomethacin-related side effects: peptic ulcer disease, renal impairment, hypertension, anticoagulation
Misdiagnosis with chronic migraine, cluster headache, or cervicogenic headache delaying appropriate therapy

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Patient with daily, unilateral, side-locked headache for over 3 months — referral to headache specialist for indomethacin trial and structured workup
  • New unilateral persistent headache in older adult or with red flags (focal deficits, visual disturbance, weight loss) — urgent imaging and secondary cause exclusion
  • Established hemicrania continua with worsening or breakthrough pain — review of dose adequacy, adherence, and consideration of alternative therapy
  • Indomethacin intolerance (gastrointestinal, renal, cardiovascular) — referral to specialist for alternative therapies and gastric protection strategy
  • Refractory hemicrania continua failing optimized medical therapy — consideration of neuromodulation interventions in tertiary headache center

Treatment Methods

01
Indomethacin trial titrated from 25 mg three times daily to 75 mg three times daily, monitoring response and gastrointestinal protection with proton pump inhibitor
02
Confirmation of complete and sustained pain relief is required for the diagnosis (indotest)
03
Alternative therapies for indomethacin-intolerant patients: celecoxib, etoricoxib, melatonin (high doses), gabapentin, topiramate, lamotrigine, lithium, or onabotulinumtoxinA
04
Greater occipital nerve blocks and supraorbital nerve blocks can provide adjunctive relief
05
Neuromodulation options under investigation: occipital nerve stimulation, sphenopalatine ganglion stimulation, vagal nerve stimulation, and CGRP-targeted therapies in selected refractory cases

Which Department to Visit?

You can visit our Nöroloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Nöroloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Headache and Migraine

Nöroloji

What you need to know about headache types, migraine attacks, and triggering factors.

Low Back Pain

Nöroloji

Learn about the most common causes of low back pain, risk factors, and appropriate treatment approaches.

Neck Pain and Cervical Disc Herniation

Nöroloji

Learn about the symptoms and treatment options for cervical disc herniation and problems in the neck region.

Epilepsy

Nöroloji

Accurate information about epilepsy, types of seizures, and recommendations for patients and families.

Parkinson Disease

Nöroloji

Parkinson disease is caused by progressive degeneration of dopaminergic neurons and alpha-synuclein accumulation; well-timed therapy substantially improves function and quality of life.

Alzheimer's Disease and Dementia

Nöroloji

Information about early signs, diagnosis, and the care process for Alzheimer's and other types of dementia.

Multiple Sclerosis (MS)

Nöroloji

What is multiple sclerosis, who is at risk, and which treatments are applied?

Stroke

Nöroloji

What is stroke, what are the FAST signs, and why is emergency intervention critical?

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.